BOSTON, MA, HilleVax, a biopharmaceutical company, announced the close of a $135 million crossover financing led by Frazier Healthcare Partners. Read More
FREMONT, CA, Alamar Biosciences, a precision proteomics company, has closed its $80 million Series B financing round led by Sherpa Healthcare Partners. Read More